Total Funding
32
12
Total FundingVenture - Series Unknown raised
Growth Score
0 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
395445
Tyrogenex is a biotechnology company researching and developing treatments for solid tumors.
Michael Webb: President and CEO
Sheridan Snyder: FounderPast Role: Biotage, Founder
About the Company
Tyrogenex, Inc., a biotechnology company, engages in research and development of multi-kinase angiogenesis inhibitor for the treatment of solid tumors. The company has developed a novel, patented cancer therapeutic, X-82, a dual VEGFR/PDGFR inhibitor. The company was formerly known as Xcovery, Inc. The company was incorporated in 2006 and is
based in West Palm Beach, Florida. The company operates as a subsidiary of Xcovery LLC.
